ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

Trial Combines Drugs Against Blood Vessel Formation

October 26, 2007

In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology

January 3, 2014